Clinical Trial Update: Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A safety and efficacy study evaluating icotinib in combination with intensity-modulated radiotherapy for nasopharyngeal carcinoma (Phase 1/Phase 2) has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• icotinib (icotinib)

Snippet

Sponsor: Taizhou Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED